Perspectives of Pharmacological Therapy of Chronic Obstructive Pulmonary Disease: Opportunities of Dual Bronchodilation and a Role of Inhaled Steroids. Expert Council Consensus

Pulmonologiya - Russian Federation
doi 10.18093/0869-0189-2016-26-1-65-72
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific and Practical Reviewed Journal Pulmonology

Related search

Inhaled Steroids in Chronic Obstructive Pulmonary Disease

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2002English

Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease

Proceedings of the American Thoracic Society
2008English

The Role of Antibiotics in Therapy of Chronic Obstructive Pulmonary Disease Exacerbations

Farmacja Polska
2018English

Inhaled Corticosteroids and Survival in Chronic Obstructive Pulmonary Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2003English

Inhaled Corticosteroids and Mortality in Chronic Obstructive Pulmonary Disease

Thorax
PulmonaryRespiratory Medicine
2005English

Clinical Benefit of Fixed-Dose Dual Bronchodilation With Glycopyrronium and Indacaterol Once Daily in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2014English

Dual Function Inhibitors of Relevance to Chronic Obstructive Pulmonary Disease

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2011English

Six-Minute Walking Versus Shuttle Walking: Responsiveness to Bronchodilation in Chronic Obstructive Pulmonary Disease

Thorax
PulmonaryRespiratory Medicine
2007English

Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease—The Shifting Treatment Paradigm

COPD: Journal of Chronic Obstructive Pulmonary Disease
MedicinePulmonaryRespiratory Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy